Cancers | Highly Cited Special Issues on Cancer Immunology and Immunotherapy in 2022
We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer immunology and immunotherapy. We hope this announcement will provide useful information for this field.
The Special Issues list is as follows:
|
|
|
|
“Tumor Immunology and Immunotherapy Resistance” |
“Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract” |
|
|
|
|
“Immunotherapy of Triple-Negative Breast Cancer” |
“Cancer Immunotherapy and Immune-Related Adverse Events” |
|
|
|
|
“Oncolytic Viruses as Cancer Immunotherapy Agents” |
“Immunotherapy for Solid Tumors” |
You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.
Cancers Editorial Office